4/A//SEC Filing
Friedman David E. 4/A
Accession 0001437749-20-005803
CIK 0001595248other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 8:28 PM ET
Size
5.8 KB
Accession
0001437749-20-005803
Insider Transaction Report
Form 4/AAmended
Genprex, Inc.GNPX
Friedman David E.
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-12-30+68,376→ 68,376 totalExercise: $1.45From: 2020-06-10Exp: 2029-12-30→ Common Stock (68,376 underlying)
Footnotes (3)
- [F1]Equal to the fair market value of a share of common stock on June 10, 2019, the date on which the option grant was to be made under the Genprex, Inc. Outside Director Compensation Policy.
- [F2]One hundred percent (100%) of the Shares subject to the Option shall vest upon the earlier of (a) the one (1) year anniversary of June 10, 2019 and (b) the day prior to the Company's next annual meeting of the Company's stockholders occurring after the grant date, provided that the Optionee continues to serve as a Service Provider (as defined in the Genprex, Inc. 2018 Equity Incentive Plan) through the applicable vesting date.
- [F3]This Form 4 amendment is being filed to reflect that on March 18, 2020, the Option was amended to provide that one hundred percent (100%) of the Shares subject to the Option became exercisable on March 18, 2020.
Documents
Issuer
Genprex, Inc.
CIK 0001595248
Entity typeother
Related Parties
1- filerCIK 0001735757
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 8:28 PM ET
- Size
- 5.8 KB